Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haskell, R. J.
Right arrow Articles by French, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haskell, R. J.
Right arrow Articles by French, W. J.

Chest, Vol 88, 70-73, Copyright © 1985 by American College of Chest Physicians

ARTICLES

Cardiac tamponade as the initial presentation of malignancy

RJ Haskell and WJ French

Although neoplastic involvement of the pericardium frequently is present postmortem, cardiac manifestations before death are uncommon, and cardiac tamponade as the initial presentation of cancer is rare. In this study, a malignancy was first recognized in eight of 23 patients (35 percent) who presented with cardiac tamponade. Seven of these eight patients had lung and one patient thyroid carcinoma. The prognosis of these eight patients was poor with seven of eight patients dead within a mean of seven weeks (range 2.5 to 16). Overall, pericardial fluid cytology demonstrated a specific diagnosis of malignancy in 14 of 19 patients (74 percent). Earlier recognition of the possibility of malignancy may allow initiation of appropriate local or systemic treatment to lessen the probability of cardiac tamponade and improve survival. We recommend that all patients who present with tamponade have cytology performed on the pericardial fluid, even if malignancy is not suspected initially.


This article has been cited by other articles:


Home page
 ANGIOLOGYHome page
R. M. Gowda, I. A. Khan, N. J. Mehta, M. R. Gowda, P. Hyde, B. C. Vasavada, and T. J. Sacchi
Cardiac Tamponade and Superior Vena Cava Syndrome in Lung Cancer: A Case Report
Angiology, November 1, 2004; 55(6): 691 - 695.
[Abstract] [PDF]

Home page
 NEJMHome page
F. J. Venditti and M. R. Pins
Case 19-1997- A 57-Year-Old Man with a Bloody Pericardial Effusion
N. Engl. J. Med., June 19, 1997; 336(25): 1812 - 1819.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the American College of Chest Physicians.